These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24465166)

  • 41. Effective separation of prolyl endopeptidase from Aspergillus Niger by aqueous two phase system and its characterization and application.
    Jiang B; Wang M; Wang X; Wu S; Li D; Liu C; Feng Z; Li J
    Int J Biol Macromol; 2021 Feb; 169():384-395. PubMed ID: 33347934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer.
    Ng L; Wan TM; Lam CS; Chow AK; Wong SK; Man JH; Li HS; Cheng NS; Pak RC; Cheung AH; Yau TC; Lo OS; Foo DC; Poon JT; Poon RT; Pang RW; Law WL
    PLoS One; 2015; 10(5):e0126219. PubMed ID: 25961724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.
    Alvarez-Sieiro P; Martin MC; Redruello B; Del Rio B; Ladero V; Palanski BA; Khosla C; Fernandez M; Alvarez MA
    Appl Microbiol Biotechnol; 2014 Aug; 98(15):6689-700. PubMed ID: 24752841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
    Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
    BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.
    Van Gool AR; Van Ojik HH; Kruit WH; Mulder PG; Fekkes D; Bannink M; Scharpé S; Stoter G; Eggermont AM; Maes M; Verkerk R
    J Interferon Cytokine Res; 2004 Jul; 24(7):411-5. PubMed ID: 15296652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor.
    Lim SW; Kim HR; Kim HY; Huh JW; Kim YJ; Shin JH; Suh SP; Ryang DW; Kim HR; Shin MG
    Cell Oncol (Dordr); 2013 Jul; 36(4):311-21. PubMed ID: 23722824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
    Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
    J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.
    Lin JK; Lin CC; Yang SH; Wang HS; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
    Int J Colorectal Dis; 2011 Sep; 26(9):1135-41. PubMed ID: 21538056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic and prognostic relevance of miR-1256 in colorectal cancer: a preliminary clinical study.
    Liu ZY; Yang L; Chang HY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7704-7709. PubMed ID: 30536313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of miR-9 correlates with poor prognosis in colorectal cancer.
    Kim H; Kim T; Jaygal G; Woo J; Kim CJ; Baek MJ; Jeong D
    Pathol Res Pract; 2020 Aug; 216(8):153044. PubMed ID: 32703504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS; Zhong B; Zhang MS; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
    Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
    Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
    Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
    BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.